Australia TGA ARTG record

Insulin syringe, fixed-needle

Australia TGA ARTG Registered Device · Interpath Services Pty Ltd · Jiangsu Caina Medical Co Ltd · Class IIa · Started April 26, 2023

Good Name: Interpath Services Pty Ltd - Insulin syringe, fixed-needle

Device classification

Risk Class: Class IIa
Product Type: Single Device Product
ARTG Category: General

Registration information

Start Date: April 26, 2023
Effective Date: April 26, 2023

Sponsor

Name: Interpath Services Pty Ltd

Manufacturer

Name: Jiangsu Caina Medical Co Ltd
Country: China
Address: No 23 Huanxi Road Zhutang Town Jiangyin City, Jiangsu, 214415

Intended purpose

Syringes for single use with integrated hypodermic cannula for subcutaneous injection of insulin

About this record

Access comprehensive regulatory information for Insulin syringe, fixed-needle in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Interpath Services Pty Ltd, manufactured by Jiangsu Caina Medical Co Ltd in China. The device registration started on April 26, 2023.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.